P2.03b-012 A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Refractory Brain Metastases and Advanced Lung Cancer
Authors:
- Seema NagpalSNSeema Nagpal
- Heather WakeleeHWHeather Wakelee
- Sukhmani PaddaSPSukhmani Padda
- Sophie BertrandSBSophie Bertrand
- Brenda AcevedoBABrenda Acevedo
- Alison Holmes TischATAlison Holmes Tisch
- Judy PagtamaJPJudy Pagtama
- Scott SoltysSSScott Soltys
- Joel NealJNJoel Neal
- 1 January 2017
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (1) , S940